A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)
Clinical trial NCT07138833 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07138833
- Sponsor
- Qilu Pharmaceutical (Hainan) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2028-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.